REDS: Net sales up 179% year-over-year; Clamp launch and US focus drive future growth

About this update from Redsense Medical Ab

Net sales surged 179% year-over-year, driven by US market strength and inventory build-up, though gross margin declined and currency volatility impacted results. Redsense Clamp is nearing commercial launch, with strategic groundwork set for Q2. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Redsense Medical Ab